ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
“It has been almost 30 years to the day since Michael, Marcia and Christa Parseghian were diagnosed with Niemann-Pick Type C disease, eventually taking their young lives. Since that time the Parseghian family and so many other families, researchers and volunteers have worked tirelessly to advance our understanding of NPC and bring treatments to those affected by this devastating disease. Today marks a momentous occasion with the FDA approval of Miplyffa and the start of a new era with the first official medication for the treatment of NPC disease. We will continue to fight for NPC families until this disease is eradicated,” Kassen said.
The APMRF is a non-profit organization dedicated to finding a treatment or cure for Niemann-Pick Type C disease. The organization is named in honor of Ara Parseghian, the much beloved and well-known Notre Dame football coach, and was founded by Mike and Cindy Parseghian, whose three children — Michael, Marcia and Christa — were diagnosed with NPC in 1994.
Latest ND NewsWire
- Notre Dame juniors Faiza Filali, Angela Olvera named Obama-Chesky Voyager ScholarsUniversity of Notre Dame juniors Faiza Filali and Angela Olvera have been named to the third cohort of Obama-Chesky Voyager Scholars. They are Notre Dame’s second and third Voyager Scholars after senior Raleigh Kuipers, who recently returned from Latin America as a member of the second cohort.
- Notre Dame theologian to receive 2024 Ratzinger Prize from VaticanCyril O’Regan, the Catherine F. Huisking Professor of Theology at the University of Notre Dame, has been selected to receive the 2024 Ratzinger Prize in Theology, widely regarded as the most prestigious award in the field. Pietro Parolin, the Vatican’s secretary of state, will present the award to O’Regan and to sculptor Etsurō Sotoo during a ceremony at the Apostolic Palace in Vatican City on Nov. 22. Both winners will also have an audience with Pope Francis earlier that day.
- Keough School invites members of the community to join in International Day of Peace eventsThe Keough School of Global Affairs will observe the International Day of Peace with two campus events: a prayer service featuring University President Rev. Robert A. Dowd, C.S.C., on Friday (Sept. 20) and a talk by a Notre Dame graduate who serves in the Sierra Leone government on Tuesday (Sept. 24). Both events are free and open to the public.
- Notre Dame to host conference on St. Thomas Aquinas, commemorating 800th anniversary of his birthTo commemorate the 800th anniversary of his birth, the University of Notre Dame will host a conference Sunday through Wednesday (Sept. 22-25) celebrating Aquinas’ enduring importance to contemporary cultural, philosophical and theological discussions. “Aquinas at 800: ‘Ad multos annos’” will be the largest conference of its kind, with more than 500 in-person attendees and more than 150 speakers.
- Global leaders discuss ‘What do we owe each other?’ in 2024-25 Notre Dame Forum Inauguration SeriesThe historic Inauguration of Rev. Robert A. Dowd, C.S.C., included a special Notre Dame Forum event on Thursday, Sept. 11, addressing this year’s…
- Labor economist seeks to understand how society continues to innovate — and why relationships are key to progressKirk Doran, an associate professor of economics, has a research mission to identify where and how new knowledge is created. He is one of four finalists from leading global institutions for the 2024 Adam Smith Panmure House Prize.